|
CLP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.137000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.127200E-01 |
| Normal-vs-Stage2 |
3.025200E-01 |
| Normal-vs-Stage3 |
6.694200E-01 |
| Normal-vs-Stage4 |
6.940300E-02 |
| Stage1-vs-Stage2 |
9.433200E-01 |
| Stage1-vs-Stage3 |
6.943600E-01 |
| Stage1-vs-Stage4 |
4.233000E-01 |
| Stage2-vs-Stage3 |
7.181600E-01 |
| Stage2-vs-Stage4 |
3.338000E-01 |
| Stage3-vs-Stage4 |
2.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.597400E-01 |
| Normal-vs-AfricanAmerican |
4.770800E-01 |
| Normal-vs-Asian |
4.848400E-01 |
| Caucasian-vs-AfricanAmerican |
6.085200E-01 |
| Caucasian-vs-Asian |
9.483800E-01 |
| AfricanAmerican-vs-Asian |
8.184400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.325160E-01 |
| Normal-vs-Female |
7.933600E-01 |
| Male-vs-Female |
1.700030E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.805400E-01 |
| Normal-vs-Extreme_Weight |
1.753600E-02 |
| Normal-vs-Obese |
4.355000E-01 |
| Normal-vs-Extreme_Obese |
4.382800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.311380E-01 |
| Normal_Weight-vs-Obese |
8.722000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.859800E-01 |
| Extreme_Weight-vs-Obese |
7.605900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.554600E-01 |
| Obese-vs-Extreme_Obese |
5.745600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.111800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.287800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.097180E-01 |
| Normal-vs-Age(81-100Yrs) |
8.271600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.196640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.617900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.713500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.914600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.794800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.941800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.415610E-01 |
| Normal-VS-Type2 PRCC |
2.813600E-01 |
| Normal-VS-KIRP CIMP |
4.416000E-01 |
| Normal-VS-Unclassified PRCC |
8.096600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.634600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.073820E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.515600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.594400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.074600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.464200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.103900E-02 |
| Normal-vs-N1 |
3.101800E-01 |
| Normal-vs-N2 |
1.959100E-03 |
| N0-vs-N1 |
1.546260E-02 |
| N0-vs-N2 |
5.654000E-02 |
| N1-vs-N2 |
2.258000E-02 |
|
|
